Lv11
50 积分 2024-09-24 加入
Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma
2小时前
已关闭
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
1个月前
已完结
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience
2个月前
已完结
Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy
3个月前
已完结
Guillain-Barré Syndrome Heralding the Diagnosis of Hodgkin Lymphoma: A Case Report
3个月前
已完结
皖公网安备34019202002308
